Virtu Financial’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-333,069
| Closed | -$30K | – | 2269 |
|
|
2023
Q3 | $30K | Buy |
+333,069
| New | +$30K | ﹤0.01% | 960 |
|
|
2023
Q2 | – | Sell |
-16,301
| Closed | -$4K | – | 2431 |
|
|
2023
Q1 | $4K | Sell |
16,301
-17,353
| -52% | -$4.26K | ﹤0.01% | 1416 |
|
|
2022
Q4 | $7K | Sell |
33,654
-4,557
| -12% | -$948 | ﹤0.01% | 1427 |
|
|
2022
Q3 | $10K | Buy |
+38,211
| New | +$10K | ﹤0.01% | 1526 |
|
|
2022
Q2 | – | Sell |
-14,483
| Closed | -$11K | – | 2408 |
|
|
2022
Q1 | $11K | Sell |
14,483
-10,726
| -43% | -$8.15K | ﹤0.01% | 1360 |
|
|
2021
Q4 | $25K | Buy |
+25,209
| New | +$25K | ﹤0.01% | 1490 |
|
|
2020
Q3 | – | Sell |
-17,586
| Closed | -$69K | – | 1803 |
|
|
2020
Q2 | $69K | Buy |
+17,586
| New | +$69K | 0.01% | 956 |
|
|
2019
Q4 | – | Sell |
-19,011
| Closed | -$13K | – | 2069 |
|
|
2019
Q3 | $13K | Sell |
19,011
-45,747
| -71% | -$31.3K | ﹤0.01% | 1331 |
|
|
2019
Q2 | $41K | Buy |
64,758
+55,409
| +593% | +$35.1K | ﹤0.01% | 1256 |
|
|
2019
Q1 | $26K | Buy |
9,349
+4,533
| +94% | +$12.6K | ﹤0.01% | 1255 |
|
|
2018
Q4 | $10K | Sell |
4,816
-536
| -10% | -$1.11K | ﹤0.01% | 1440 |
|
|
2018
Q3 | $25K | Buy |
5,352
+3,368
| +170% | +$15.7K | ﹤0.01% | 1379 |
|
|
2018
Q2 | $9K | Buy |
1,984
+1,433
| +260% | +$6.5K | ﹤0.01% | 1905 |
|
|
2018
Q1 | $4K | Sell |
551
-267
| -33% | -$1.94K | ﹤0.01% | 1872 |
|
|
2017
Q4 | $6K | Buy |
818
+287
| +54% | +$2.11K | ﹤0.01% | 2280 |
|
|
2017
Q3 | $4K | Buy |
+531
| New | +$4K | ﹤0.01% | 2445 |
|